serum c-peptide was measured fasting and 6 minutes after glucagon ( 1 mg given intravenously ) in 49 patients with non-insulin-dependent diabetes mellitus , after 4 and 6 months of successive periods of treatment with insulin and oral hypoglycaemics ( glibenclamide and metformin ) , given in random order .
C0006558
c-peptide
C0011849
non-insulin-dependent diabetes mellitus